Real-World Outcomes Favor Standard Care in HER2-Positive Metastatic Breast Cancer



(MedPage Today) — At the San Antonio Breast Cancer Symposium (SABCS), a large retrospective analysis of U.S. electronic health records compared outcomes for patients with HER2-positive metastatic breast cancer who received first-line guideline…



Source link : https://www.medpagetoday.com/meetingcoverage/sabcsvideopearls/118926

Author :

Publish date : 2025-12-10 14:00:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version